SCHEMBL2611705

SCHEMBL2611705

Cc1cc(C)cc(COc2ccc(C(C)(c3ccc(OCc4cc(C)cc(C)c4)cc3)c3cc(C(C)(c4ccc(OCc5cc(C)cc(C)c5)cc4)c4ccc(OCc5cc(C)cc(C)c5)cc4)cc(C(C)(c4ccc(OCc5cc(C)cc(C)c5)cc4)c4ccc(OCc5cc(C)cc(C)c5)cc4)c3)cc2)c1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PARP10 Q53GL7 1/20 0.53
▸ APP P05067 1/20 0.45
▸ HDAC8 Q9BY41 2/20 0.44
▸ MAOB P27338 7/20 0.41
▸ NR4A2 P43354 1/20 0.41
▸ RXRA P19793 1/20 0.41
▸ RXRB P28702 1/20 0.41
▸ PPARG P37231 1/20 0.39
▸ PPARD Q03181 1/20 0.39
▸ PPARA Q07869 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ HRH3 Q9Y5N1 1/20 0.38
▸ TSPO P30536 1/20 0.37
▸ MRGPRX4 Q96LA9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14456121 0.97 PARP10 (0.55) PARP10APPHDAC8MAOBNR4A2
SCHEMBL14456122 0.92 PARP10 (0.51) PARP10APPHDAC8MAOBNR4A2
SCHEMBL29303960 0.86 APP (0.60) PARP10APPHDAC8MAOBNR4A2
SCHEMBL14461958 0.83 APP (0.45) PARP10APPMAOBNR4A2RXRA
SCHEMBL13609105 0.80 MRGPRX4 (0.44) PARP10APPPPARGPPARDPPARA
SCHEMBL14422350 0.79 APP (0.47) PARP10APPMAOBNR4A2RXRA
SCHEMBL5370546 0.77 PARP10 (0.65) PARP10APPHDAC8MAOBALDH1A1
SCHEMBL14456128 0.75 APP (0.44) APPMAOBNR4A2RXRARXRB
SCHEMBL14422352 0.75 APP (0.44) APPMAOBNR4A2RXRARXRB
SCHEMBL3439660 0.75 PARP10 (0.58) PARP10HDAC8MAOBALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8771923-B2 Radiation-sensitive composition JSR CORPORATION (JP) 2014-07-08 — — US disclosed
US-8771923-B2 Radiation-sensitive composition JSR CORPORATION (JP) 2014-07-08 — — US disclosed
US-20130108962-A1 RADIATION-SENSITIVE COMPOSITION JSR CORPORATION (JP) 2013-05-02 — — US disclosed
US-20130108962-A1 RADIATION-SENSITIVE COMPOSITION JSR CORPORATION (JP) 2013-05-02 — — US disclosed
US-8361691-B2 Radiation-sensitive composition and process for producing low-molecular compound for use therein JSR CORPORATION (JP) 2013-01-29 — — US disclosed
US-8361691-B2 Radiation-sensitive composition and process for producing low-molecular compound for use therein JSR CORPORATION (JP) 2013-01-29 — — US disclosed
US-20120100481-A1 ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE COMPOSITION AND PATTERN FORMING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2012-04-26 — — US disclosed
US-20090280433-A1 RADIATION-SENSITIVE COMPOSITION AND PROCESS FOR PRODUCING LOW-MOLECULAR COMPOUND FOR USE THEREIN JSR CORPORATION (JP) 2009-11-12 — — US disclosed
US-20090280433-A1 RADIATION-SENSITIVE COMPOSITION AND PROCESS FOR PRODUCING LOW-MOLECULAR COMPOUND FOR USE THEREIN JSR CORPORATION (JP) 2009-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090280433-A1 RADIATION-SENSITIVE COMPOSITION AND PROCESS FOR PRODUCING LOW-MOLECULAR COMPOUND FOR USE THEREIN ACP1, PLG, ALG1 PARP10 1734/4885APP 3172/4885HDAC8 1490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback